Cutler Group LP Cytokinetics Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Cutler Group LP holds 603 shares of CYTK stock, worth $29,251. This represents 0.01% of its overall portfolio holdings.

Number of Shares

603

Previous 30,200 98.0%

Holding current value

$29,251

Previous $817,000 94.86%

% of portfolio

0.01%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$63.75 - $108.06 $38,441 - $65,160	603 New	603 $42,000
Q3 2023 Nov 07, 2023	BUY	$29.46 - $36.61 $73,650 - $91,525	2,500 New	2,500 $73,000
Q4 2022 Feb 07, 2023	BUY	$35.77 - $51.11 $357 - $511	10 New	10 $0
Q1 2022 Apr 14, 2022	SELL	$29.74 - $46.0 $8,029 - $12,420	-270 Reduced 13.96%	1,664 $61,000
Q4 2021 Jan 18, 2022	BUY	$34.35 - $46.38 $66,055 - $89,188	1,923 Added 17481.82%	1,934 $88,000

Q3 2021 Oct 26, 2021	SELL	$18.54 - $35.74 $9,066 - $17,476	-489 Reduced 97.8%	11 $0
Q2 2021 Jul 19, 2021	SELL	$19.79 - $26.99 $1,979 - $2,699	-100 Reduced 16.67%	500 $9,000
Q1 2021 Apr 26, 2021	SELL	$18.57 - $25.68 $128,133 - $177,192	-6,900 Reduced 92.0%	600 $13,000
Q4 2020 Jan 21, 2021	SELL	$15.26 - $28.61 $7,630 - $14,305	-500 Reduced 6.25%	7,500 $155,000
Q3 2020 Oct 27, 2020	BUY	$20.58 - $28.96 $164,640 - $231,680	8,000 New	8,000 $173,000
Q1 2019 May 10, 2019	SELL	$5.95 - $10.19 $50,575 - $86,615	-8,500 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$5.91 - $9.29 $50,235 - $78,965	8,500 New	8,500 $53,000
Q3 2018 Nov 07, 2018	SELL	$6.4 - $9.85 $640 - $985	-100 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$6.9 - $9.9 $8,280 - $11,880	-1,200 Reduced 92.31%	100 $0
Q1 2018 May 11, 2018	SELL	$7.2 - $10.05 $20,160 - $28,140	-2,800 Reduced 68.29%	1,300 $9,000
Q4 2017 Jan 17, 2018	SELL	$7.25 - $15.65 $44,087 - $95,167	-6,081 Reduced 59.73%	4,100 $33,000
Q3 2017 Oct 17, 2017	BUY	$12.0 - $15.0 $122,172 - $152,715	10,181	10,181 $147,000

Others Institutions Holding CYTK

# of Institutions

459

Shares Held

108M

Call Options Held

7.2M

Put Options Held

6.2M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account